
Top 5 Articles of the Week: April 20-25
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters. This week, the US FDA approved dupilumab (Dupixent; Regeneron and Sanofi) for the treatment of chronic spontaneous urticaria (CSU) in patients aged 12 years and older …